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Abstract
Background:  Colorectal cancer screening rates are low among disadvantaged patients; few
studies have explored barriers to screening in community health centers. The purpose of this study
was to describe barriers to/facilitators of colorectal cancer screening among diverse patients
served by community health centers.
Methods:  We identified twenty-three outpatients who were eligible for colorectal cancer
screening and their 10 primary care physicians. Using in-depth semi-structured interviews, we
asked patients to describe factors influencing their screening decisions. For each unscreened
patient, we asked his or her physician to describe barriers to screening. We conducted patient
interviews in English (n = 8), Spanish (n = 2), Portuguese (n = 5), Portuguese Creole (n = 1), and
Haitian Creole (n = 7). We audiotaped and transcribed the interviews, and then identified major
themes in the interviews.
Results: Four themes emerged: 1) Unscreened patients cited lack of trust in doctors as a barrier
to screening whereas few physicians identified this barrier; 2) Unscreened patients identified lack
of symptoms as the reason they had not been screened; 3) A doctor's recommendation, or lack
thereof, significantly influenced patients' decisions to be screened; 4) Patients, but not their
physicians, cited fatalistic views about cancer as a barrier. Conversely, physicians identified
competing priorities, such as psychosocial stressors or comorbid medical illness, as barriers to
screening. In this culturally diverse group of patients seen at community health centers, similar
barriers to screening were reported by patients of different backgrounds, but physicians perceived
other factors as more important.
Conclusion: Further study of these barriers is warranted.
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Background
Colorectal cancer is the second leading cause of cancer
death in the US. In 2007, an estimated 153,760 people
will be diagnosed with colorectal cancer, and it is esti-
mated that 52,180 will die of the disease [1]. Despite the
availability of effective screening tests [2-6] a large propor-
tion of Americans are still not being screened for colorec-
tal cancer [7-9]. Patients at greatest risk of not being
screened include racial and ethnic minorities [9,10],
patients with Medicaid or no health insurance [7,11,12],
the foreign born [11,13], and patients with low socioeco-
nomic status [14] – groups that are commonly served by
community health centers [7,15].
Researchers have identified and explored numerous barri-
ers to colorectal cancer screening [7,16]. Quantitative
studies have found the following to be barriers specific to
poor and underserved populations: demographic factors
(insurance, social class, and race/ethnicity) [12,17-21],
language, embarrassment, lack of knowledge about color-
ectal cancer screening [22] culture-specific beliefs [10],
and level of acculturation [23]. Qualitative studies have
characterized such barriers in more detail, and have
sought to answer the question of why poor and minority
patients are not being screened. Such studies have
included white, African-American [24], Latino and Chi-
nese patients [25], and have found fear (of both pain and
of discovering cancer), shame of being seen as sick or
weak, feelings of violation, mistrust, and fatalism to be
barriers to screening. Patients also reported that they did
not know where to obtain screening, and had difficulty in
obtaining an appointment for screening [25]. Yet prior
qualitative studies have not included patients from Brazil,
Portugal, the Azores, Cape Verde or Haiti, large immigrant
groups in Massachusetts and elsewhere in the US, and
none have simultaneously interviewed each patient's pri-
mary care provider.
Our study had two primary objectives: 1) to identify and
describe barriers to and facilitators of screening in an eth-
nically diverse population of patients served by commu-
nity health centers and 2) to compare patients' and
physicians' views regarding the reasons why patients did
not receive screening. We used qualitative methods to
obtain in-depth information from patients and their phy-
sicians.
Methods
Setting and participants
Cambridge Health Alliance is a regional healthcare system
with three hospitals and more than twenty primary-care
centers in Cambridge, Somerville, and Everett, MA. Cam-
bridge Health Alliance also includes the Cambridge Pub-
lic Health Department and Network Health, a managed
Medicaid plan. Designated by the Agency for Health Care
Quality and Research (AHRQ) as a Primary Care Practice-
Based Research Network, the health centers predomi-
nantly serve a multi-cultural, low-income population.
At the time of the study, January 2005–December 2006,
most of the health centers used a limited electronic clini-
cal data system (Meditech) that included patient demo-
graphics, medical visit information, and diagnostic test
results. There was no organized screening program in
place at the time of the study; patients were offered screen-
ing on an ad-hoc basis during primary care visits. Among
patients receiving care at 8 different community health
centers, we identified patients aged 52–80 who appeared
to be unscreened for colorectal cancer. Since the database
did not capture diagnostic tests performed outside of the
health center network, we anticipated that some patients
who appeared unscreened would in fact have received
colorectal cancer screening. We included these patients in
our study as we sought both to understand barriers to
screening as well as factors that facilitated screening. We
based eligibility for colorectal cancer screening on a mod-
ified version of the most recent HEDIS measure [26]. The
denominator of the measure included any patient aged
52–80 who had one visit to a primary care physician in a
community health center in each of the 2 previous years.
The numerator of the measure included any patient who
received colonoscopy in the past 10 years, sigmoidoscopy
or barium enema in the past 5 years, or fecal occult blood
testing (FOBT) during each measurement year.
We limited our sample to patients who spoke English,
Portuguese, Portuguese Creole, Spanish and Haitian Cre-
ole, and whose primary care physicians had the most
patients in the age range of interest (52–80). This sample
included 301 patients. We then e-mailed the 13 primary
care physicians of these patients and invited them to par-
ticipate in the study; all agreed to participate. All patients
in the study were cared for by one or more of the primary
care physicians in the study. We thus interviewed a con-
venience sample of patients and primary care physicians,
excluding patients with active substance abuse (where,
according to the physician, the patient would not be able
to participate in the interview in a meaningful way), a his-
tory of colorectal cancer, or mental retardation. The Insti-
tutional Review Board at the Cambridge Health Alliance
approved the study protocol. All participating patients
and physicians provided written informed consent.
Data collection
We conducted semi-structured individual interviews with
patients to obtain in-depth information about why
patients who were eligible for colorectal cancer screening
had or had not been screened, respectively. For
unscreened patients, we also interviewed each patient's
physician to gain their perspective regarding the reasonBMC Family Practice 2008, 9:15 http://www.biomedcentral.com/1471-2296/9/15
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their patient had not been screened. Since our goal was to
obtain a broad range of information to understand
patients' screening decisions, we included both screened
and unscreened patients. Known as "maximum variation
sampling," this sampling approach is used in qualitative
research to encompass a broader variety of perspectives
[27].
A primary care physician (KEL) and a medical sociologist
with expertise in qualitative research (MG) developed an
open-ended, semi-structured interview instrument to
explore subjects' experiences with colorectal cancer
screening. The investigators piloted the interview instru-
ment with patients, and revised the instrument accord-
ingly. In developing the instrument, we reviewed the
extensive ethnographic colorectal cancer screening litera-
ture to ensure that our instrument encompassed barriers
and facilitators encountered by other researchers working
with comparable underserved and deprived patient popu-
lations [24,28]. Our interview instrument is available as
Additional file 1.
We delivered probes in an order that was based on how
the interview unfolded. The initial portion of the instru-
ment elicited pertinent aspects of the subject's cultural,
family, and educational history. We also assessed specific
cognitive knowledge of colorectal cancer and the role of
colorectal cancer screening. In the second portion of the
interview, we asked participants to recall and to describe
in detail their experience discussing colorectal cancer
screening with the person they identified as their primary
care physician. We probed participants about logistical
barriers to obtaining screening (lack of transportation,
inability to take time off from work, child care responsi-
bilities), health beliefs (that colorectal cancer screening is
harmful, unhelpful, painful), psychological symptoms or
conditions that may relate to completing screening (fears
of cancer, fear of leaving one's home or riding on public
transportation, inability to keep appointments due to
depression, PTSD symptoms related to prior sexual
abuse), distrust of the medical system (paranoia, feeling
of being used as a "guinea pig"), fatalism, social stressors
(financial and housing instability), and comorbid health
problems. At the conclusion of the interview, we asked
participants demographic questions.
We mailed a letter (translated into the non-English lan-
guages) signed by each patient's primary care physician
inviting the patient to participate in a voluntary 45-
minute interview with one of the investigators (KEL), and
with an interpreter for the non-English speaking patients,
about the patient's experiences obtaining services to pre-
vent colorectal cancer. We offered a $25 cash incentive to
participate. Patient interviews lasted one-half to one hour.
We conducted the interviews either in the patient's home
or in a research office, according to each patient's prefer-
ence. To interview patients in their primary language, we
trained two medical interpreters to assist with the non-
English interviews. One interpreter was bilingual in Eng-
lish and in Haitian Creole, and the other interpreter was
trilingual in English, Spanish, and Portuguese (including
Portuguese Creole).
We also developed an open-ended, semi-structured inter-
view instrument to explore physicians' experiences dis-
cussing colorectal cancer screening with their patients.
During the interview, we asked each physician the follow-
ing question: "I recently met with your patient ______.
What sorts of things do you think prevented him/her from
getting screened?" Prior to each interview, we asked phy-
sicians to confirm that they were in fact the patient's pri-
mary care physician, and to review the medical record of
their patients who had not been screened. The physician
interviewer also reviewed each patient's medical record to
validate the patient's report of their screening status, and
to document any efforts made by the physician to screen
the patient. Physicians also completed a brief question-
naire about their demographic characteristics. We offered
physicians a $50 cash incentive to participate; interviews
lasted one-half to one hour.
Data analysis
We audiotaped the interviews, with the exception of one
patient who declined audiotaping. For that patient, we
took detailed notes of the interview. We submitted the
audiotapes to an experienced qualitative transcriptionist
who transcribed them verbatim. For the non-English lan-
guage interviews, only the English-language portions
(which the interpreter had translated into English) were
transcribed. One investigator (KEL) checked the tran-
scripts for accuracy, listening to portions of the audiotape
while reading the typed transcription. Two investigators, a
primary care physician (KEL) and a medical sociologist
(MG) coded and analyzed all of the transcripts. We cre-
ated codes that reflected patient and physician responses
regarding the reasons the patient had not been screened
for colorectal cancer. During frequent meetings, we dis-
cussed discrepancies in coding and resolved them by con-
sensus. Using the constant comparative method [29], we
revised original themes after we compared them with
newer themes that emerged in the coding process. We
compared themes across cases to ensure that they were
both representative and inclusive of all cases. We also
compared individual patient and physician perspectives
regarding the reasons each patient was not screened. Due
to the small sample size, we did not calculate reliability
statistics.BMC Family Practice 2008, 9:15 http://www.biomedcentral.com/1471-2296/9/15
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Results
Table 1 shows the demographic characteristics of the 23
patients who were interviewed. Sixteen patients had not
received colorectal cancer screening; the remaining 7
patients had either been screened (n = 3) or had received
a diagnostic colonoscopy (n = 4) for workup of gastroin-
testinal symptoms. Most patients were female, non-white,
had a low level of education, and had an annual income
of less than $15,000. The mean age of participants was
60.9, and nearly all had some form of health insurance.
Of the three patients who had undergone colorectal can-
cer screening, one had a colonoscopy, and 2 were screened
by FOBT cards. We also interviewed the 10 primary care
physicians of the 16 patients who had not been screened.
Half of the physicians were female, most were white (n =
8), and their mean age was 46.
Four consistent themes emerged from our analyses of
patient interviews: 1) Unscreened patients cited lack of
trust in doctors as a major barrier to screening whereas few
physicians identified this barrier in their patients; 2)
Unscreened patients identified lack of symptoms as the
reason they had not been screened; 3) A doctor's recom-
mendation, or lack thereof, significantly influenced
patients' decisions to be screened; 4) Patients, but not
their physicians, cited fatalistic views about cancer as a
barrier. Most patients and physicians cited more than one
barrier to screening. Table 2 lists barriers cited most fre-
quently by patients and physicians, respectively. Below we
discuss each theme in detail with illustrative verbatim
quotations.
Lack of trust
Five of 16 unscreened patients (3 white US-born patients,
1 African-American patient, and one white Portuguese
patient from the Azores) cited a lack of trust in doctors as
one of the major reasons they had not been screened for
colorectal cancer. For example, a white woman from the
Azores related that her husband had suffered from oral
cancer: "I really don't trust doctors... I really believe that
...all the treatment just helped to kill him faster. So I
always tell my daughters if, God forbid...if anything hap-
pens to me, I don't want any of that [treatment]." Her phy-
sician, a native speaker of Portuguese, recognized that a
lack of trust was affecting her patient's decision not to be
screened:
"It's a trust issue...She's from the Azores [part of Portu-
gal]... going to the doctor was really a last resort when
nothing else, when the local remedies...would not
help...Also, we had a dictatorship in Portugal at the
time, and there was a secret police as well...people
grew up not knowing who to trust...they knew that
they were safe within the home, but anything outside
of the home was different."
A US-born white man also cited lack of trust in doctors as
one of the reasons he had not been screened:
"I have issues around trust, and whether or not things
will be done in my best interests...Maybe they want
more operations to do. Gee we want to find out if
there's more cancer because our surgeons aren't work-
ing enough. We can't give enough radiation. We want
more business, so we want to look for more cancer."
While this patient's physician did not identify lack of trust
as a reason why the patient was unscreened, he did cor-
rectly identify psychosocial stressors as another reason the
patient had not been screened: "...all I know is he was an
[older] guy who was in love with a ... [younger] woman,
Table 1: Patient characteristics (n = 23)
Characteristics
Female (%) 60.9
Mean Age (range) 62.3 (52–74)
Race (%)
White 34.8
Black 39.1
Other 26.1
Hispanic or Latino origin (%) 26.1
Health Insurance (%)
Private 4.3
Medicare 21.7
Medicaid 39.1
Free Care1 30.4
Uninsured 4.3
Primary Language (%)
English 34.8
Portuguese/Portuguese Creole 26.1
Spanish 8.7
Haitian Creole 30.4
Education (%)
Less than high school 47.8
High School only/Vocational/Trade 26.1
College or higher 26.1
Annual Income (%)
< $5,000 17.4
$5,000–$9,999 34.8
$10,000–$14,999 21.7
≥ $15,000 17.4
Don't know/refused 8.7
Employment (%)
Employed full or part-time 69.6
Retired 13.0
Unemployed 17.4
Screened for Colorectal Cancer (%)
Yes 30.4
No 69.6
1After being determined ineligible for other payment options, 
Massachusetts residents can apply for help paying for health center 
bills from the Massachusetts uncompensated (free) care pool.BMC Family Practice 2008, 9:15 http://www.biomedcentral.com/1471-2296/9/15
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and was dealing with all those kinds of issues, and had
recently left his wife, and it was just sort of a social mess..."
Trust in doctors was a facilitator of screening for 2 of 7 of
the screened patients (1 white US-born patient and 1
Spanish-speaking patient from El Salvador). The Salva-
doran woman related that she had had a good experience
seeing a doctor in El Salvador for a gynecologic complaint.
She said of her current primary care doctor: "I'm not plan-
ning on stopping seeing her until either I die or something
happens to her that she cannot see me again."
Lack of symptoms
Five of the 16 unscreened patients (2 white US-born
patients, 2 African-American patients, and one Portuguese
patient from the Azores) cited a lack of symptoms as one
of the reasons why they had not been screened, while 4 of
the 7 patients who appeared to have been screened had in
fact had diagnostic colonoscopies to work up the etiology
of gastrointestinal symptoms (2 Portuguese-speaking
patients from Brazil, 1 Spanish-speaking patient from El
Salvador, and 1 Portuguese-Creole speaking patient from
Cape Verde). An unscreened English-speaking white
woman told us: "You guys want me to have an examina-
tion; I'll tell you something, I have the world's best diges-
tive system..." At the same time, her physician cited
comorbid medical illnesses as one reason she had not
been screened: "She has really poorly controlled choles-
terol and blood pressure, so I imagine it hasn't come up
because she's so resistant to taking her blood pressure
medicine..." Her physician also said, "I just know her per-
sonally, she doesn't want anything done..." A second
patient, also an English-speaking white woman, related: "I
only go to the doctor if something is hanging off my body
or I'm bleeding..." Her physician recalled that she refused
to complete FOBT cards, and added:
"I think she was sent to me because she's a psych
patient and they sent her down for a primary care phy-
sician...I don't recall her having a strong motivation to
see a primary care physician and get medical care... I
have this vague picture of her as not highly motivated
to participate in this medical intervention that was
going on and in a hurry to get out and ... I think I felt
that I had made a major accomplishment by telling
her to go to the dentist."
A doctor's recommendation
Two of 7 screened patients (both Haitian-Creole speaking
patients from Haiti) cited a doctor's recommendation as a
facilitator of screening, while 5 out of 16 unscreened
patients (1 white US-born patient, 3 Haitian-Creole
speaking patients from Haiti, and 1 Spanish-speaking
patient from El Salvador) said their doctor had not recom-
mended screening. The importance of a doctor's recom-
mendation, while cited by patients speaking Spanish,
English, and Haitian Creole, was especially prominent
among Haitian patients. Of the 5 Haitian patients who
had not been screened, 3 said they had not been screened
because their doctor had not recommended screening.
When queried about colorectal cancer screening, one
patient replied "I don't know anything about it...the doc-
tor never asked me to do it." Both of the Haitian patients
who had been screened reported that they had completed
the tests based on their doctor's recommendation.
When we reviewed the medical records of the 5 patients
who stated that their doctor had never recommended
screening, it appeared that in 2 instances (including one
in which the physician was a native speaker of Haitian
Creole), a discussion about colorectal cancer screening
had indeed taken place, as each physician had referred the
patient for a colonoscopy. Most Haitian patients reported
that if their doctor recommended screening then they
would be screened. One man explained: "Doctor come
[sic] after God. After God, it's doctors."
Some physicians were aware that they had not recom-
mended screening, often because of competing priorities
– their own priorities or those of the patient. For example,
one physician gave the following explanation for why she
had not discussed colorectal screening with her patient:
"I think she is a psychologically fragile, a very anxious
lady who has been taking care of a disabled hus-
band...And she has been quite overwhelmed. And
she's also been dealing with her pulmonary condition
which I think has been much more acute. So I think
Table 2: Most frequently cited barriers to colorectal cancer screening identified by patients and by their primary care physicians
Barriers identified by patients Barriers identified by Physicians
1. Lack of trust (n = 5) 1. Psychosocial issues (n = 6)
2. Lack of symptoms (n = 5) 2. Comorbid medical illness (n = 4)
3. No doctor's recommendation (n = 5) 3. Screening is lower priority (n = 3)
4. Fatalistic views about cancer (n = 3) 4. Patient does not seek preventive care (n = 5)BMC Family Practice 2008, 9:15 http://www.biomedcentral.com/1471-2296/9/15
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it's a combination of doing a lot of acute stuff and per-
sonal issues..."
Fatalism
Three of 16 unscreened patients expressed fatalistic views
about cancer as one of the reasons they had not been
screened; two of these patients were African-American
men, and the third was a woman of Portuguese descent
from the Azores. In each case, the physician was not aware
that the patient held fatalistic views about cancer. One
African-American man told us: "...Well, I don't want to
[get screened for colon cancer] because, hey, you know, I
mean, if you got it you got it, but they can't do anything
to cure me..." His physician, when asked why the patient
was not screened, replied:
"...My impression was that a lot of things got in the
way of him getting screened. It seemed like in every
progress note, almost every one... the colonoscopy was
scheduled, but not done and rescheduled and not
done... I know at one point his wife had died. He has
a history of substance use, so that interfered. But to
what extent his views about colon cancer screening
interfered with that, I don't really have a good sense of
that..."
Another African-American man, who reported that his
father had died from colorectal cancer, related: "I figure if
it's [cancer] going to be there it's going to be there. That's
the outlook I have." This patient also reported that he was
afraid of finding out that he has cancer if he gets the tests
done. His physician listed several other reasons why this
patient had not been screened. The physician noted a lack
of connection between him and the patient, as the patient
often consulted other providers at the health center. He
also felt that colorectal cancer screening was a lower prior-
ity for this patient:
"...There's been the substance abuse issue, there's been
a significant musculoskeletal problem... [which] kept
him out of work for a long time. Precarious financial,
social and home life situation, so all of those things
we've been aware of and we've addressed..."
The physician also reported that the patient does not seek
preventive care: "He's always come for intermittent com-
plaints or for minor crises in his personal or his medical
life. He's never been somebody who seems to have
engaged in regular routine health maintenance..." The
physician then added, "I don't believe... that anybody
actually asked the question about colon cancer."
Discussion
In this qualitative study of ethnically and linguistically
diverse patients receiving care at 8 community health
centers in the Boston area, we observed that the 4 follow-
ing principal factors may prevent patients from being
screened for colorectal cancer: distrust of doctors, lack of
symptoms, lack of a physician recommendation for
screening, and fatalistic beliefs about cancer. Patients of
differing race, ethnicity, and language mentioned these
factors. It is possible that what these patients have in com-
mon – poverty and limited educational attainment – may
underlie these barriers to screening.
Why might patients be distrustful of colorectal cancer
screening? For African Americans, the legacy of the Tuske-
gee syphilis experiment and the persistence of health dis-
parities have been shown to decrease their trust in doctors
or health care [30]. Others have implicated physicians'
interpersonal skills [31] and a lack of continuity in care
[32] as contributors to a lack of trust. In our study, several
patients trusted their own physician and had regular
ongoing care at a community health center. Yet these
patients feared that other physicians (such as gastroenter-
ologists, medical oncologists, radiation oncologists and
surgeons) would not act in their best interests. It is also
possible that fatalistic views about cancer underpin a lack
of trust. If a patient believes that a cancer diagnosis will
inevitably lead to death, yet their doctor or health care sys-
tem is promoting an invasive procedure to detect the can-
cer, the patient may begin to distrust his or her doctor's
motives. Why would their doctor promote a test to detect
an incurable disease? Perhaps an in-depth discussion with
a physician about colorectal cancer screening would help
to educate and reassure patients about their concerns. Yet
for some patients, physicians cited a preponderance of
other medical and psychosocial issues they felt compelled
to address, thereby precluding them from conducting
even a brief discussion of colorectal screening.
The other barriers to screening we identified, lack of symp-
toms or of a doctor's recommendation, have been found
in a prior study of the U.S. population [9], and our study
suggests that these factors may also apply to specific
groups that have not been analyzed previously, including
Portuguese, Brazilian and Haitian patients. We found that
Haitian patients, in particular, cited the lack of a physician
recommendation as the main reason they were not
screened, and they reported a willingness to comply with
any recommendation made by their physicians. Yet when
we reviewed these patients' charts, we found that in some
cases the physician had in fact recommended colorectal
cancer screening. This finding suggests a communication
problem during the visit – even when there was no lan-
guage barrier between a patient and his or her physician.
In contrast to prior studies [33], we observed that systems
issues, such as long wait times for colonoscopy did not
appear to be a major barrier to colorectal cancer screening.
It is possible that the barriers we encountered (such as lackBMC Family Practice 2008, 9:15 http://www.biomedcentral.com/1471-2296/9/15
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of a physician recommendation and lack of trust) lie
"upstream" to potential systems issues. If patients are not
pursuing screening they are not encountering these sys-
tems barriers.
Conclusion
Our study provides insight into potential barriers to color-
ectal cancer screening facing disadvantaged patients
served by community health centers. A strength of our
research is that we included groups in which colorectal
cancer screening has not been widely studied, including
patients from Haiti, Brazil, the Azores, and Cape Verde.
Our study has several limitations. The findings from our
sample of poor, ethnically, and linguistically diverse
patients who receive care at urban community health
centers may not be generalizable to other patient popula-
tions. Yet our findings may be generalizable to enclaves of
similar patients elsewhere. Our sample was limited to
small numbers of patients in each language group, and to
a small number of screened patients. Thus, it is unlikely
that saturation was reached in our study. We did not back-
translate the non-English language translations. However,
our physician interviewer spoke fluent Spanish, Portu-
guese, and French and could assess the validity of the
interpreting for most of the non-English language inter-
views. Our use of qualitative methods precludes us from
estimating the prevalence of the barriers we identified
among all patients receiving care at community health
centers. Finally, interview coding may be subjective.
Disparities in colorectal cancer screening rates according
to the race, ethnicity, and socioeconomic status of
patients have been well documented [9,10,13,17-
19,34,35]. Because community health centers provide
care to many disadvantaged patients, these centers are an
ideal setting in which to design and implement interven-
tions to improve screening rates. One such intervention
might include a community health worker component,
where such workers would provide telephone-based out-
reach to patients identified in the administrative database
as not having received screening. Our preliminary find-
ings suggest that it is possible that such interventions
could be applied broadly, without substantial tailoring
related to the ethnic or linguistic background of patients.
Addressing lack of trust in doctors and fatalistic beliefs
about cancer – barriers that have not been typically
addressed in previous interventions and may occur in all
ethnic groups – may improve the success of efforts to pro-
mote screening in community health centers. Unburden-
ing primary care physicians of the entire responsibility of
addressing all preventive services, perhaps by enlisting the
assistance of other members of the health care team, may
also increase screening rates.
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